| Primary |
| Product Used For Unknown Indication |
50.6% |
| Crohn's Disease |
10.8% |
| Rheumatoid Arthritis |
9.5% |
| Psoriasis |
3.8% |
| Hypertension |
3.7% |
| Psoriatic Arthropathy |
2.8% |
| Pain |
2.7% |
| Depression |
2.1% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Insomnia |
1.5% |
| Hypersensitivity |
1.4% |
| Vitamin Supplementation |
1.4% |
| Blood Cholesterol Increased |
1.3% |
| Ankylosing Spondylitis |
1.1% |
| Migraine |
1.1% |
| Nausea |
1.1% |
| Colitis Ulcerative |
0.9% |
| Hypothyroidism |
0.9% |
| Diabetes Mellitus |
0.8% |
| Anxiety |
0.8% |
|
| Vomiting |
11.4% |
| Weight Decreased |
11.4% |
| Injection Site Pain |
10.2% |
| Pain |
5.7% |
| Death |
4.5% |
| Pneumonia |
4.5% |
| Sepsis |
4.5% |
| Small Intestinal Obstruction |
4.5% |
| Surgery |
4.5% |
| Urinary Tract Infection |
4.5% |
| Drug Ineffective |
3.4% |
| Injection Site Reaction |
3.4% |
| Intestinal Obstruction |
3.4% |
| Intestinal Stenosis |
3.4% |
| Lung Neoplasm Malignant |
3.4% |
| Myocardial Infarction |
3.4% |
| Rash |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Urticaria |
3.4% |
| Vision Blurred |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
39.3% |
| Crohn's Disease |
11.1% |
| Rheumatoid Arthritis |
10.2% |
| Hypertension |
5.6% |
| Pain |
4.3% |
| Psoriasis |
4.1% |
| Psoriatic Arthropathy |
3.4% |
| Depression |
2.9% |
| Vitamin Supplementation |
2.4% |
| Nausea |
2.2% |
| Colitis Ulcerative |
2.0% |
| Hypothyroidism |
1.7% |
| Migraine |
1.7% |
| Blood Cholesterol Increased |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Hypersensitivity |
1.4% |
| Insomnia |
1.4% |
| Ankylosing Spondylitis |
1.2% |
| Diabetes Mellitus |
1.2% |
| Anxiety |
1.0% |
|
| Vomiting |
9.6% |
| Rheumatoid Arthritis |
7.7% |
| Gastrointestinal Inflammation |
5.8% |
| Macrocytosis |
5.8% |
| Psoriasis |
5.8% |
| Umbilical Hernia |
5.8% |
| Urinary Tract Infection |
5.8% |
| Viral Upper Respiratory Tract Infection |
5.8% |
| Wrong Technique In Drug Usage Process |
5.8% |
| Abdominal Pain |
3.8% |
| Colectomy |
3.8% |
| Injection Site Pain |
3.8% |
| Nasopharyngitis |
3.8% |
| Oedema |
3.8% |
| Pain |
3.8% |
| Paraesthesia |
3.8% |
| Pyrexia |
3.8% |
| Rectal Haemorrhage |
3.8% |
| Sinusitis |
3.8% |
| Skin Haemorrhage |
3.8% |
|
| Concomitant |
| Hypothyroidism |
33.3% |
| Prostatitis |
33.3% |
| Rheumatoid Arthritis |
33.3% |
|
| Fatigue |
50.0% |
| Semen Volume Decreased |
50.0% |
|
